Skip to main content
Sirnaomics Ltd. logo

Sirnaomics Ltd. — Investor Relations & Filings

Ticker · 2257 ISIN · KYG2050P1028 LEI · 2549004JEEDTBC6EHW37 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 406 across all filing types
Latest filing 2026-05-28 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 2257

About Sirnaomics Ltd.

http://www.sirnaomics.com

Sirnaomics Ltd. is a clinical-stage RNA therapeutics biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs. The company's pipeline addresses a broad spectrum of therapeutic areas, including oncology, fibrosis-related diseases, skin conditions, antiviral and cardiometabolic diseases, and medical aesthetics. Sirnaomics utilizes proprietary delivery platforms, which form the foundation of its RNA-based therapeutics. These platforms include the Polypeptide Nanoparticle (PNP) system for administering mRNA vaccines and therapeutics, and the GalNAc delivery platform for systemic administration of liver-targeting RNA interference (RNAi) therapeutics. The company is recognized as the first to achieve positive Phase IIb clinical outcomes in oncology using clinical-stage RNA therapeutics.

Recent filings

Filing Released Lang Actions
PROXY FORM
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a proxy form for shareholders to appoint proxies and vote at the company’s upcoming Annual General Meeting (AGM). It is clearly part of the materials sent to solicit votes, fitting the definition of a Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND BUY BACK SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED RE-APPOINTMENT OF AUDITOR, PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a ‘‘circular’’ sent by the Board to shareholders ahead of the Annual General Meeting, containing the notice of meeting, resolutions (general mandates to issue/buy back shares, re-election of directors, re-appointment of auditor, amendments to the memorandum and articles), an explanatory statement, and a form of proxy. These are classic elements of a proxy solicitation and information statement provided to shareholders to request votes at an AGM. It is not the Annual Report itself, nor merely an announcement of a report, nor a board/management change notice. Under the defined categories, this best fits Proxy Solicitation & Information Statement (PSI).
2026-05-28 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal notice of the upcoming Annual General Meeting of Sirnaomics Ltd., outlining the date, location, agenda items, and proxy voting instructions. It is sent to shareholders to request votes on the proposed resolutions. This matches the definition of a Proxy Solicitation & Information Statement (PSI) rather than the AGM presentation materials or a mere regulatory announcement.
2026-05-28 English
SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 95% confidence The document is a formal stock exchange announcement by a listed company detailing the terms of a subscription agreement for the allotment and issuance of 2,435,600 new shares under the company’s general mandate. It describes the subscription price, conditions precedent, lock-up, effects on shareholding, and application for listing of the new shares. This is precisely an announcement of a new share issue/capital change, matching the Share Issue/Capital Change category (Code: SHA).
2026-05-25 English
PROPOSED TERMINATION OF EXISTING SHARE OPTION SCHEME AND ADOPTION OF SHARE OPTION SCHEME
Share Issue/Capital Change Classification · 75% confidence The document is an official announcement by Sirnaomics Ltd.’s board proposing the termination of the existing share option scheme and adoption of a new 2026 Share Option Scheme. It outlines conditions for shareholder approval at an extraordinary general meeting and future issuance of shares under the option scheme. This relates to potential future share issuance and changes in the company’s capital structure rather than reporting of financial results or operational matters. Therefore, it falls under Share Issue/Capital Change (SHA).
2026-04-22 English
CHANGE OF COMPANY LOGO
Regulatory Filings Classification · 85% confidence The document is a Hong Kong Stock Exchange announcement (prefaced with the HKEX disclaimer) regarding a corporate identity change (company logo) for Sirnaomics Ltd. It is not a financial report, board/management change, dividend, or other specific category. It is a general regulatory announcement, thus best classified under Regulatory Filings (RNS).
2026-04-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.